Skip to main content
Top
Published in: Inflammation Research 3/2018

01-03-2018 | Letter to the Editor

Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa

Author: Valerio De Vita

Published in: Inflammation Research | Issue 3/2018

Login to get access

Excerpt

I have read with interest the paper by Shah and colleagues [1]. The authors have underlined that macrophages play a critical role in the pathogenesis of hidradenitis suppurativa (HS). Dysregulation of macrophage activity is a big culprit in causing chronic tissue inflammation and damage. More specifically, dysregulated activation and proliferation of macrophages contribute to elevated macrophage secretion of pro-inflammatory cytokines and matrix metalloproteases (MMPs), which activate other inflammatory effectors and directly lead to tissue injury. In particular, macrophages are the most numerous inflammatory cells found in HS infiltrate and release numerous pro-inflammatory cytokines such as interleukin (IL)-23 [2], IL-1b [3] and tumour necrosis factor (TNF)-alpha [3, 4], which work to further enhance the inflammation. As a result, macrophages may modify the pericellular environment by influencing other inflammatory cells and may act as key players in the pathogenesis of the disease. This evidence helps to understand why HS patients often have concurrent inflammatory conditions which are also characterized by macrophage dysfunction such as Crohn’s disease and spondyloarthropathy. …
Literature
1.
go back to reference Shah A, Alhusayen R, Amini-Nik S. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflamm Res. 2017;66:931–945CrossRefPubMed Shah A, Alhusayen R, Amini-Nik S. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflamm Res. 2017;66:931–945CrossRefPubMed
2.
go back to reference Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96–105.CrossRefPubMed Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004;202:96–105.CrossRefPubMed
3.
go back to reference Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of psoriasis. Arch Dermatol Res. 2011;303:691–705.CrossRefPubMed Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of psoriasis. Arch Dermatol Res. 2011;303:691–705.CrossRefPubMed
5.
go back to reference Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441:1–21.CrossRefPubMed Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441:1–21.CrossRefPubMed
6.
go back to reference Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–84.CrossRefPubMed Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471–84.CrossRefPubMed
8.
go back to reference Balato A, Di Caprio R, Lembo S, Mattii M, Megna M, Schiattarella G, et al. Mammalian target of rapamycin in inflammatory skin conditions. Eur J Inflamm. 2014;12:341–50.CrossRef Balato A, Di Caprio R, Lembo S, Mattii M, Megna M, Schiattarella G, et al. Mammalian target of rapamycin in inflammatory skin conditions. Eur J Inflamm. 2014;12:341–50.CrossRef
9.
go back to reference Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, Fabbrocini G. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25:153–125.CrossRefPubMed Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, Fabbrocini G. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients’ skin. Exp Dermatol. 2016;25:153–125.CrossRefPubMed
10.
go back to reference Monfrecola G, Balato A, Caiazzo G, De Vita V, Di Caprio R, Donnarumma M, et al. Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop. J Eur Acad Dermatol Venereol. 2016;30:1631–3.CrossRefPubMed Monfrecola G, Balato A, Caiazzo G, De Vita V, Di Caprio R, Donnarumma M, et al. Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: a possible metabolic loop. J Eur Acad Dermatol Venereol. 2016;30:1631–3.CrossRefPubMed
11.
go back to reference Linke M, Fritsch SD, Sukhbaatar N, Hengstschläger M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591:3089–103.CrossRefPubMed Linke M, Fritsch SD, Sukhbaatar N, Hengstschläger M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591:3089–103.CrossRefPubMed
12.
13.
go back to reference Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun. 2013;4:2834.CrossRefPubMedPubMedCentral Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun. 2013;4:2834.CrossRefPubMedPubMedCentral
15.
go back to reference Geeraerts X, Bolli E, Fendt SM, Van Ginderachter JA. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol. 2017;8:289.CrossRefPubMedPubMedCentral Geeraerts X, Bolli E, Fendt SM, Van Ginderachter JA. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol. 2017;8:289.CrossRefPubMedPubMedCentral
16.
go back to reference Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684.CrossRefPubMedPubMedCentral Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 2016;5:e11612.CrossRefPubMedPubMedCentral Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 2016;5:e11612.CrossRefPubMedPubMedCentral
Metadata
Title
Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa
Author
Valerio De Vita
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 3/2018
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-017-1115-6

Other articles of this Issue 3/2018

Inflammation Research 3/2018 Go to the issue